DE MICCO, ROSA
 Distribuzione geografica
Continente #
EU - Europa 2.328
AS - Asia 1.690
NA - Nord America 1.031
SA - Sud America 292
AF - Africa 32
Continente sconosciuto - Info sul continente non disponibili 1
OC - Oceania 1
Totale 5.375
Nazione #
RU - Federazione Russa 1.305
US - Stati Uniti d'America 998
SG - Singapore 598
CN - Cina 372
IE - Irlanda 340
IT - Italia 271
HK - Hong Kong 268
BR - Brasile 250
VN - Vietnam 121
KR - Corea 115
DE - Germania 108
GB - Regno Unito 88
JP - Giappone 77
IN - India 51
FR - Francia 49
UA - Ucraina 42
SE - Svezia 28
FI - Finlandia 24
TR - Turchia 24
GR - Grecia 23
AR - Argentina 18
CA - Canada 18
ZA - Sudafrica 14
AT - Austria 11
ID - Indonesia 10
CZ - Repubblica Ceca 9
IQ - Iraq 9
MX - Messico 9
MA - Marocco 8
UZ - Uzbekistan 8
CO - Colombia 7
JO - Giordania 7
NL - Olanda 7
PK - Pakistan 7
BD - Bangladesh 6
PL - Polonia 6
EC - Ecuador 5
ES - Italia 5
BE - Belgio 4
PE - Perù 4
AZ - Azerbaigian 3
KZ - Kazakistan 3
RO - Romania 3
DK - Danimarca 2
DZ - Algeria 2
IL - Israele 2
JM - Giamaica 2
KE - Kenya 2
LK - Sri Lanka 2
PH - Filippine 2
PY - Paraguay 2
TN - Tunisia 2
UY - Uruguay 2
VE - Venezuela 2
AE - Emirati Arabi Uniti 1
AU - Australia 1
BO - Bolivia 1
BS - Bahamas 1
CG - Congo 1
CI - Costa d'Avorio 1
CL - Cile 1
EE - Estonia 1
EG - Egitto 1
EU - Europa 1
GD - Grenada 1
GE - Georgia 1
HN - Honduras 1
KW - Kuwait 1
LB - Libano 1
LT - Lituania 1
NG - Nigeria 1
PA - Panama 1
PT - Portogallo 1
TM - Turkmenistan 1
Totale 5.375
Città #
Moscow 427
Dublin 340
Singapore 273
Hong Kong 266
Santa Clara 266
Seoul 115
Hefei 98
Jacksonville 76
New York 64
Naples 58
Chandler 56
Ashburn 49
Beijing 45
Bengaluru 44
Ho Chi Minh City 40
Princeton 34
Bremen 32
Roxbury 32
Munich 30
Hanoi 27
The Dalles 26
Medford 23
São Paulo 23
Los Angeles 19
Napoli 18
Caserta 13
Cambridge 12
Wilmington 12
Boardman 11
Helsinki 11
London 11
Avella 10
Dallas 10
Falkenstein 10
Nuremberg 10
Reggio Emilia 10
Brno 9
Des Moines 9
Istanbul 8
Rome 8
Tashkent 8
Amman 7
Ann Arbor 7
Curitiba 7
Jinan 7
Johannesburg 7
Nanjing 7
Norwalk 7
Da Nang 6
Manchester 6
Ninh Bình 6
Rio de Janeiro 6
Shanghai 6
Stockholm 6
Turku 6
Vienna 6
Casoria 5
Haiphong 5
Milan 5
Montreal 5
Trento 5
Viterbo 5
Warsaw 5
Woodbridge 5
Zhengzhou 5
Aversa 4
Belo Horizonte 4
Bogotá 4
Boston 4
Cape Town 4
Casablanca 4
Ercolano 4
Hangzhou 4
Lima 4
Ningbo 4
Phoenix 4
Porto Alegre 4
Sacramento 4
Salvador 4
Shenzhen 4
Acerra 3
Afragola 3
Amsterdam 3
Athens 3
Baku 3
Barra Mansa 3
Biên Hòa 3
Brooklyn 3
Brussels 3
Duque de Caxias 3
Frankfurt am Main 3
Giugliano in Campania 3
Guangzhou 3
Ha Long 3
Houston 3
Hải Dương 3
Manaus 3
Mountain View 3
Palermo 3
Pelotas 3
Totale 2.905
Nome #
A transient third cranial nerve palsy as presenting sign of spontaneous intracranial hypotension 138
Clinical correlations of microstructural changes in progressive supranuclear palsy 118
Cognitive impairment is associated with Hoehn and Yahr stages in early, de novo Parkinson disease patients 114
Medical retrofitting design 114
Advanced visual network and cerebellar hyperresponsiveness to trigeminal nociception in migraine with aura 106
Central pain processing in "drug-naïve" pain-free patients with Parkinson's disease 105
Cognitive and morphometric features of mild cognitive impairment reversion in early patients with Parkinson's disease 101
Continuous intra jejunal infusion of levodopa-carbidopa intestinal gel by jejunal extension tube placement through percutaneous endoscopic gastrostomy for patients with advanced Parkinson's disease: a preliminary study 101
Non-motor impairments affect walking kinematics in Parkinson disease patients: A cross-sectional study 98
Resting-state network connectivity changes in drug-naive Parkinson's disease patients with probable REM sleep behavior disorder 97
Rhythm-specific modulation of the sensorimotor network in drug-naive patients with Parkinson's disease by levodopa. 96
Cortical thickness changes in patients with Parkinson's disease and impulse control disorders 96
Fatigue in Parkinson's disease: Italian validation of the Parkinson Fatigue Scale and the Fatigue Severity Scale using a Rasch analysis approach 94
Arterial spin labeling MRI applied to migraine: current insights and future perspectives 93
Validation of the Italian version of carers’ quality-of-life questionnaire for parkinsonism (PQoL Carer) in progressive supranuclear palsy 93
Cognitive Networks Disarrangement in Patients With Migraine Predicts Cutaneous Allodynia 91
Olfactory loss and brain connectivity after COVID-19 90
Development and Validation of Automated Magnetic Resonance Parkinsonism Index 2.0 to Distinguish Progressive Supranuclear Palsy-Parkinsonism From Parkinson's Disease 88
Fatigue in Parkinson's disease: A systematic review and meta-analysis 87
Intrinsic brain connectivity predicts impulse control disorders in patients with Parkinson's disease 83
A Bayesian approach to Essential Tremor plus: A preliminary analysis of the TITAN cohort 82
Correlates of the discrepancy between objective and subjective cognitive functioning in non-demented patients with Parkinson’s disease 81
Brain Networks and Cognitive Impairment in Parkinson's Disease 78
Validation of new diagnostic criteria for fatigue in patients with Parkinson disease 76
Memory Phenotypes In Early, De Novo Parkinson's Disease Patients with Mild Cognitive Impairment 76
Connectivity Correlates of Anxiety Symptoms in Drug-Naive Parkinson's Disease Patients 76
Effectiveness and safety of an atropine/midazolam and target controlled infusion propofol-based moderate sedation protocol during percutaneous endoscopic transgastric jejunostomy procedures in Parkinson’s disease: a real-life retrospective observational study 75
Altered domain-specific striatal functional connectivity in patients with Parkinson's disease and urinary symptoms 74
Functional connectivity underpinnings of fatigue in "Drug-Naïve" patients with Parkinson's disease 74
Effects of safinamide on non-motor, cognitive, and behavioral symptoms in fluctuating Parkinson's disease patients: a prospective longitudinal study 73
Resting-state brain networks in patients with Parkinson's disease and impulse control disorders 73
Olfactory Loss and Brain Connectivity after COVID-19: Structural Follow-Up at One Year 72
Correction to: Spinocerebellar ataxia 27B: a frequent and slowly progressive autosomal-dominant cerebellar ataxia—experience from an Italian cohort 71
Motor, behavioural, and cognitive correlates of fatigue in early, de novo Parkinson disease patients 71
Cerebro-cerebellar motor networks in clinical subtypes of Parkinson's disease 70
Galcanezumab effect on "whole pain burden" and multidimensional outcomes in migraine patients with previous unsuccessful treatments: a real-world experience 69
A Novel Compound Heterozygous Mutation in Aprataxin Causes Slowly Progressive Ataxia without Oculomotor Apraxia 68
Correlates of psychological distress in epileptic patients during the COVID-19 outbreak 68
Intrinsic brain functional connectivity predicts treatment-related motor complications in early Parkinson’s disease patients 67
Resting-state functional connectivity associated with mild cognitive impairment in Parkinson’s disease 67
Comparing Essential Tremor with and without Soft Dystonic Signs and Tremor Combined with Dystonia: The TITAN Study 64
Spinocerebellar ataxia 27B: a frequent and slowly progressive autosomal-dominant cerebellar ataxia—experience from an Italian cohort 64
Resting-State Functional MRI Approaches to Parkinsonisms and Related Dementia 64
Predictors of fatigue severity in early, de novo Parkinson disease patients: A 1-year longitudinal study 63
Skin Biopsy May Help to Distinguish Multiple System Atrophy-Parkinsonism from Parkinson's Disease With Orthostatic Hypotension 62
Can we predict development of impulsive–compulsive behaviours in Parkinson’s disease? 60
Structural MRI in Idiopathic Parkinson's Disease 60
The psychological correlates of fatigue in Parkinson's disease: Contribution of maladaptive metacognitive beliefs 59
Fading of brain network fingerprint in Parkinson's disease predicts motor clinical impairment 58
Sex-related pattern of intrinsic brain connectivity in drug-naïve Parkinson's disease patients 57
Correlates of Psychological Distress in Patients with Parkinson's Disease During the COVID-19 Outbreak 56
Supplementary motor area functional connectivity in “drug-naïve” Parkinson’s disease patients with fatigue 55
Flexible brain dynamics underpins complex behaviours as observed in Parkinson's disease 54
Clinical correlates of “pure” essential tremor: the TITAN study 54
Validation of the Italian version of the PSP Quality of Life questionnaire 54
Multidisciplinary care use in neurodegenerative complex diseases: The example of progressive supranuclear palsy and advanced Parkinson's disease in real-life 53
Subjective memory decline in Parkinson's disease patients with and without fatigue 53
Speech Rhythm Variation in Early-Stage Parkinson's Disease: A Study on Different Speaking Tasks 52
SCAR32: Functional characterization and expansion of the clinical‐genetic spectrum 51
Distinctive Handwriting Signs in Early Parkinson’s Disease 50
Family History in Parkinson's Disease: A National Cross‐Sectional Study 49
Functional Connectivity Signatures of Parkinson's Disease 48
Increased glucosylsphingosine levels and Gaucher disease in GBA1-associated Parkinson's disease 47
Kufor Rakeb syndrome without gaze palsy and pyramidal signs due to novel ATP13A2 mutations 47
The Italian tremor Network (TITAN): rationale, design and preliminary findings 46
Impulse control behaviors in Parkinson's disease: Drugs or disease? Contribution from imaging studies 46
Functional motor phenotypes: to lump or to split? 45
Pain and fatigue in Parkinson's disease: advances in diagnosis and management 42
Functional motor disorders associated with other neurological diseases: Beyond the boundaries of "organic" neurology 42
Functional Connectomics and Disease Progression in Drug-Naïve Parkinson's Disease Patients 41
REM behavior disorder predicts motor progression and cognitive decline in Parkinson disease 39
Levodopa Equivalent Dose of Safinamide: A Multicenter, Longitudinal, Case–Control Study 38
Molecular Imaging Markers to Track Huntington’s Disease Pathology 37
Levodopa-carbidopa intrajejunal infusion in Parkinson's disease: untangling the role of age 37
Editorial: Non-motor Symptoms in Primary Motor Neurological Disorders: From Molecular Pathways to Clinical and Therapeutic Implications 34
HPDL Biallelic Variants in Cerebral Palsy and Childhood‐Onset Hereditary Spastic Paraplegia: Human and Zebrafish Insights 31
A Short Version of Carers' Quality of Life Questionnaire for Parkinsonism: Data from Progressive Supranuclear Palsy Network 30
Characterising alexithymia in individuals with functional motor disorders: a cross-sectional analysis of the Italian Registry of Functional Motor Disorders 28
A Short Progressive Supranuclear Palsy Quality of Life Scale: Data from the PSP‐NET 28
Clinical trial eligibility in PSP: Population representativeness and potential criteria adjustment based on PSP-NET findings 27
Functional Changes of the Perigenual Part of the Anterior Cingulate Cortex after External Trigeminal Neurostimulation in Migraine Patients 22
Analyzing Information Exchange in Parkinson’s Disease via Eigenvector Centrality: A Source-Level Magnetoencephalography Study 22
LC-MS/MS-Based Determination of Ambroxol in Human Plasma and Cerebrospinal Fluid: Validation and Applicability in a Phase II Study on GBA-Associated Parkinson’s Disease Patients 17
Effects of GBA1 Variants in Patients With Parkinson's Disease and Levodopa–Carbidopa Intestinal Gel: A Nation‐Wide, Multicenter, Longitudinal, “Real‐World” Study. The EPIC Study 16
The Complex Pathway of Conventional Investigations before the Diagnosis of Functional Motor Disorders 14
Gender Is the Main Predictor of Wearing‐Off and Dyskinesia in Levodopa‐Naïve Patients with Parkinson's Disease 14
Psychometric properties and clinical correlates of the Frontal Behaviour Inventory in progressive supranuclear palsy: data from the PSP-NET 13
Early classification of functional connectomes in Parkinson’s disease: a comparison of machine learning classifiers using multi-scale topological features 7
Totale 5.514
Categoria #
all - tutte 21.232
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 21.232


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202184 0 0 0 0 0 3 29 11 5 9 24 3
2021/2022244 9 9 1 10 70 4 6 8 13 21 25 68
2022/2023483 43 8 6 23 53 19 2 13 292 13 5 6
2023/2024374 28 16 18 17 110 79 9 5 1 8 27 56
2024/20251.233 8 28 7 29 226 181 169 132 162 103 91 97
2025/20262.762 244 392 250 291 448 1.137 0 0 0 0 0 0
Totale 5.514